Chapter 22: Bernadette's Molecular Contribution
Bernadette's voice had acquired the particular edge it got when experimental data refused to cooperate.
"The binding affinity should be 3.2 nanomolar," she said, stabbing a piece of broccoli with unnecessary force. "Every model we have predicts 3.2 nanomolar. The actual result? 8.7. Every single time."
Wednesday evening dinner at apartment 4A had devolved into pharmaceutical research analysis approximately fifteen minutes ago. Howard was watching his wife with the expression of someone who had learned to recognize this mood and had chosen to stay quiet until it passed.
Raj looked up from his plate. "Is that... bad?"
"It's inexplicable." Bernadette set down her fork. "The compound shouldn't behave this way. The receptor structure is standard, the ligand configuration is standard, the environmental conditions are controlled to the fourth decimal. And yet."
Adam listened without interrupting. The Molecular Conductor's passive mode registered the conversation at a purely informational level — pharmaceutical kinetics, receptor dynamics, the specific vocabulary of someone who worked at the molecular interface between chemistry and biology.
Different from Amy's focus. Binding affinity mechanics instead of addiction pathways. Related substrates, different applications.
"What's the secondary binding site doing?" Adam asked.
Bernadette stopped mid-reach for her wine glass.
"What?"
"The secondary binding site. If the primary affinity is off by that margin, the compound might be catching something downstream. Allosteric interference, maybe. Conformational change in the receptor that's not showing up on your static models."
Bernadette looked at him for three full seconds.
Then she set down the wine glass and turned in her chair to face him directly.
"You're right. We assumed the secondary site was inert because the crystallography suggested stable conformation. But if the compound is inducing a conformational shift before the primary binding event..."
She trailed off, already running calculations internally. Adam could see it in her eyes — the specific intensity of someone who had just received a useful piece of information.
"That would explain the discrepancy," she continued. "The 8.7 result isn't wrong — it's measuring the combined effect. We've been modeling the wrong interaction sequence."
"Bernie, you're doing science at the dinner table," Howard said.
"Science doesn't stop because we're eating Thai food, Howard."
"Actually," Raj offered, "I think Thai food is specifically designed to stop science. Too much coconut milk. Impairs cognitive function."
Penny snorted from the kitchen doorway. "That's not a thing."
"It's absolutely a thing. I read about it."
"Where?"
"Somewhere."
Adam let the conversation drift around him. The Molecular Conductor's passive register was processing Bernadette's explanation in the background — the binding affinity mechanics, the conformational dynamics, the specific way pharmaceutical compounds interacted with neural receptor structures at the molecular level.
This bridges with Amy's neurochemistry data. The substrate overlap is significant.
The warmth behind his sternum shifted. The Synthesis Core was making connections.
Twenty minutes later, the conversation had moved through three topics and returned to Bernadette's research. She was describing the specific protein structure involved, the way the receptor's extracellular domain responded to ligand presence, the cascade effects that resulted from conformational change.
Adam asked questions. Bernadette answered them at full technical register — she had stopped simplifying approximately fifteen minutes ago.
The Molecular Conductor's passive mode crossed a threshold.
Adam went very still for one second. Maybe less. The encoding completed itself: pharmaceutical compound dynamics at an operational level, bridging with the neurochemistry base he had built from Amy's explanations, generating a working model of biological systems that had not existed in his architecture that morning.
He blinked. Continued the conversation.
"— so the conformational shift propagates through the transmembrane domain before it reaches the intracellular signaling cascade," Bernadette finished. "Which is why our kinetic model was wrong. We were measuring the wrong timepoint."
"That makes sense," Adam said.
Bernadette studied him.
"You understand pharmaceutical binding dynamics."
"I have some background in molecular systems."
"No." She shook her head. "You understand it. That's different."
Howard looked up from his plate. "He does that. Understands things he shouldn't technically understand."
"Yes, I know." Bernadette's expression had shifted into something Adam recognized: professional assessment. "I've been watching."
The table went quiet for a moment.
Then Penny's voice came from the kitchen:
"He does that with everyone."
The group turned to look at her. She was leaning against the counter, water glass in hand, her tone casual in a way that suggested she had been thinking about this for a while.
"What?" She shrugged. "He pays attention."
Raj nodded slowly. "That's true. He's a very good listener."
"It's not listening," Penny said. "It's..." She searched for the word. "Absorbing. Like he's taking notes that nobody else can see."
Notes that nobody else can see.
Adam did not let his expression change.
"I come from a research background that emphasizes observation," he said. "Academy City methodology tends to prioritize comprehensive data collection."
"Uh-huh." Penny took a sip of water. "Sure."
She did not push further. But her eyes stayed on him for another three seconds before she returned to the kitchen.
---
The evening wound down in the usual way. Bernadette and Howard left first — Bernadette was already planning experimental modifications in her head, her fingers tapping against her thigh in a pattern that probably represented protein structures.
"I'm going to run the conformational analysis tomorrow," she told Adam at the door. "If you're right about the secondary site, it'll show up in the molecular dynamics simulation."
"Let me know what you find."
"I will." She paused. "You have good instincts for this."
"Thank you."
She nodded and left with Howard. Adam stayed another twenty minutes, helping Raj clean up the containers while Leonard and Penny argued about something in the kitchen that had nothing to do with pharmaceutical research.
Normal. Comfortable. The cover that kept getting harder to call a cover.
---
Walking home, the Pasadena evening had cooled enough to be almost comfortable. Adam's hands stayed warm regardless.
Three observers, three methodologies.
Sheldon's investigation was formal: calibration logs, taxonomy updates, evidence accumulation. He was looking for a category that fit. He would keep looking until he found one or gave up, and Sheldon did not give up.
Bernadette was different. She observed competence the way a scientist observed data — professionally, precisely, without the emotional charge that Sheldon brought to his categorizations. She had filed him under "anomalous expertise" and would continue accumulating evidence until the anomaly resolved itself or became interesting enough to investigate.
And Penny.
Penny saw things she could not explain and held them without organizing them. She had called it "absorbing." She had said "notes that nobody else can see."
She is the most accurate observer in the room and she does not have a framework for what she is seeing.
Adam reached his apartment building. The lights in the fourth-floor hallway were on. Someone was watching television downstairs — the sound carried through the walls in the specific way cheap Pasadena apartments allowed.
He went upstairs, opened his notebook, and wrote: "Three observers, three methodologies. Manage separately."
He looked at the sentence for a long moment.
Then he added: "Penny's methodology is the most dangerous because it does not require a conclusion to be effective. She is holding observations without organizing them. When she decides to organize them, the picture will be more accurate than Sheldon's."
The warmth in his forearms was elevated by half a degree. He went to the bathroom, ran cold water over his hands for thirty seconds, and watched the heat dissipate into the drain.
The pharmaceutical binding dynamics are useful. The exposure cost is manageable. The group's shared observation is attributable to "pays attention."
For now.
He dried his hands and went to bed.
Get Early Access to New Chapters
Thank you for reading. For those who want to skip the wait, my Patreon is currently 21 chapters ahead of the public sites.
Schedule: 7 new chapters released every 10 days.
Benefit: Gain a significant lead of 7 to 21 chapters depending on your tier.
Support the project and start reading the next arc now: Patreon.com/IsekaiStories